Vaccine Race Tightens with BioNTech Candidate Still "On Track"

BNTX is already up 586% year-over-year

Digital Content Manager
Oct 15, 2020 at 10:14 AM
facebook X logo linkedin

With COVID-19 vaccine trials being put on hold left and right, at least one candidate remains on track. That is according to Ugur Sahin, chief executive officer of BioNTech SE (NASDAQ:BNTX), who said in an interview to Bloomberg that the late-stage trial of a coronavirus vaccine the biotech company is developing with Pfizer (PFE) is moving forward. Sahin added that side effects are in line with those seen in earlier studies, and that they may be able to say whether the vaccine works as soon as this month, since late-stage trials were not stopped due to safety concerns. As a result, shares are up 2.4% at $88.92 at last check.

Over the last several months, the equity has experienced the volatile rollercoaster ride that is the race for a COVID-19 vaccine. The stock had two major rallies in March and July, and while shares hit an all-time-high of $105 on March 18, BNTX was ultimately not able to sustain those levels. The rally in July fell just short of that March peak.

Despite a jaw-dropping 586% year-over-year lead, analysts are mostly hesitant towards the security, with four of the seven in coverage carrying a tepid "hold," and the remaining three sporting a "strong buy." Meanwhile, the 12-month consensus target price of $80.87 is an 6.9% discount to the stock's current perch.

The options pits lean more bullish, with calls popular. In the last 50 days, 18,145 calls have been exchanged, compared to just 7,224 puts. Yet, shorts have been building their positions, too. Short interest is up 30.1% in the last reporting period, with 6.66 million shares sold short.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI